Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

I-Acute Lymphoblastic Leukemia (T-ALL)-06

Isigulana: Xiaohong

Isini: Indoda

Ubudala: Uneminyaka emi-2 ubudala

Ubuzwe: IsiTshayina

Uxilongo:I-Acute Lymphoblastic Leukemia (T-ALL)

    Isigulana sabantwana esineminyaka emi-2 ubudala esine-T-ALL sifumana ukuphumla emva konyango lwe-CAR-T emva kokufumana i-chemotherapy enzulu izihlandlo ezingaphezu kweshumi.


    UXiaohong oneminyaka emibini ubudala waseZhejiang wafunyaniswa ene-leukemia ehlotyeni elidlulileyo. Emva konyango olungaphezu konyaka, i-flow cytometry yafumanisa ukuba isifo siphinde sabuyela esiqhelweni, nto leyo eyakhokelela ekubeni usapho lufune unyango lwe-CAR-T immunotherapy kwi-BIOOCUS Medical Group.


    Ngomhla wesi-9 kweyeThupha, ngowama-2020, uXiaohong wangeniswa kwisibhedlele sabantwana sasekuhlaleni ngenxa "yomkhuhlane weentsuku ezintathu." Uvavanyo lwe-MICM yomongo lwafumanisa ukuba une-acute lymphoblastic leukemia (T-ALL). Emva kwekhosi enye ye-chemotherapy, i-bone marrow morphology yabonisa ukuxolelwa okupheleleyo, kwaye i-flow cytometry ayizange ifumane iiseli ezinobungozi ezingavuthwanga. I-chemotherapy enzulu eyalandelayo kwiikhosi ezili-11 yagcina ukuxolelwa okupheleleyo komongo wethambo.


    Ngomhla wesi-3 kuSeptemba 2021, ukugqobhozwa komnkantsha wethambo okulandelayo kwabonisa ukuxolelwa ngokupheleleyo kwimo yeseli, kodwa i-flow cytometry yabonisa iiseli ezingavuthwanga eziyi-1.85%. Efuna unyango olongezelelweyo, uXiaohong wangeniswa kwiziko lethu le-CGT ngomhla wama-24 kuSeptemba. Emva kokungeniswa, imo yemnkantsha wethambo yayisekwimo yemnkantsha epheleleyo, kodwa i-immunophenotyping yabonisa ukuba ii-lymphocytes ze-T ezingavuthwanga ziyi-0.10%.


    Ngenxa yokuba uXiaohong wayesemncinci kwaye esi sifo siqhubeke ixesha elide nangona wayefumana unyango oluqatha lwe-chemotherapy, iqela lezonyango kwicandelo lesibini le-hematology lagqiba kwelokuba uXiaohong angabhalisa kuvavanyo lweklinikhi lwe-CD7 CAR-T.


    Ngomhla wama-30 kuSeptemba, ngo-2021, kwaqokelelwa iiseli zegazi ezingaphandle ukuze kukhuliswe iiseli ze-CAR-T. Ngomhla we-10 kuOkthobha, uXiaohong wafumana i-FC regimen chemotherapy. Ngomhla we-13 kuOkthobha, ukubhobozwa kwethambo lomongo kwabonisa ukuqhuma okungaphantsi kwe-5% kwi-morphology, kwaye i-flow cytometry yabonisa iiseli ze-T ezingekavuthwa ezingama-0.37%. Ngomhla we-15 kuOkthobha, iiseli ze-CD7 CAR-T zaphinda zafakwa.


    Ngomhla wesi-3 kweyoMqungu (iintsuku ezingama-20 emva kokufakelwa kwakhona), ukubhobozwa komongo wethambo kwabonisa ukuxolelwa ngokupheleleyo kwimo yeseli, kungekho ziseli zingavuthwanga ezifunyenweyo yi-flow cytometry. Imeko kaXiaohong izinzile ukususela ngoko, kwaye udluliselwe kwicandelo lokufakelwa ukuze alungiselele ukufakelwa kweseli ye-hematopoietic stem.


    UXiaohong wayengaphantsi konyaka ubudala xa wagula waza wanyamezela unyango lwamayeza unyaka wonke. Ukuphumelela ekutshintsheni iseli emva konyango lwe-CD7 CAR-T kuye kwanika isixhobo esinamandla sokuphelisa ngokupheleleyo esi sifo.

    4mm3

    Ukususela ngoJulayi 2015, iziko lethu le-CGT liqalise uvavanyo lweklinikhi lwe-CAR AT cell therapy kwizifo zegazi. Njengenye yeeyunithi zokuqala zokuqala unyango lwe-CAR-T cell eTshayina, izigulane ezili-1342 zingene kolu vavanyo ukuza kuthi ga ngoku, kwaye idatha yeklinikhi ibonisa ukusebenza kakuhle kunye nokhuseleko olulawulekayo. I-CD7 yi-glycoprotein engama-40 kDa eyinxalenye ye-immunoglobulin superfamily, kwaye i-CD7 eqhelekileyo ibonakaliswa kakhulu kwiiseli ze-T kunye neeseli ze-NK kunye nakwizigaba zokuqala zokwahlulwa kweeseli ze-T, B kunye ne-myeloid, kwaye inokusebenza njenge-costimulatory receptor yokusebenzisana phakathi kwee-lymphocytes ze-T kunye ne-B ngexesha lophuhliso lwe-lymphocyte. I-CD7 luphawu oluzinzileyo kakhulu kumphezulu weseli ye-T kwaye okwangoku ivavanywa njengethagethi entsha kunye nonyango lwe-CAR T cell kwi-hematological malignancies. Kutshanje, kwiwadi yesibini yeSebe leHematology leSibhedlele saseLudaopei, izigulane ezi-4 ezineemeko ezinzima zifumene iziphumo ezicacileyo emva konyango lwe-CD7 CAR-T.

    inkcazo2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write